NAESX
Price
$141.37
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
VSPRX
Price
$15.91
Change
-$0.10 (-0.62%)
Updated
Jul 31 closing price
Net Assets
211.69M
Interact to see
Advertisement

NAESX vs VSPRX

NAESX vs VSPRX Comparison Chart in %
View a ticker or compare two or three
VS
NAESX vs. VSPRX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAESX is a Hold and VSPRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 189B vs. VSPRX (212M). NAESX pays higher dividends than VSPRX: NAESX (1.10) vs VSPRX (0.71). NAESX was incepted earlier than VSPRX: NAESX (66 years) vs VSPRX (11 years). VSPRX (0.80) is less costly to investors than NAESX (0.17). VSPRX is a more actively managed with annual turnover of: 111.00 vs. NAESX (17.00). NAESX (0) and VSPRX (0) have matching initial minimum investment requirements. NAESX annual gain was more profitable for investors over the last year : 22.56 vs. VSPRX (19.27). NAESX return over 5 years is better than : 34.95 vs. VSPRX (-20.85).
NAESXVSPRXNAESX / VSPRX
Total Expense Ratio0.170.8021%
Annual Report Gross Expense Ratio0.170.8021%
Fund Existence66 years11 years-
Gain YTD14.5638.969162%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets189B212M89,151%
Annual Yield % from dividends1.100.71155%
Returns for 1 year22.5619.27117%
Returns for 3 years43.3012.41349%
Returns for 5 years34.95-20.85-168%
Returns for 10 years155.28-12.92-1,202%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMMSX32.150.39
+1.23%
Vanguard Emerg Mkts Sel Stk Inv
VRGWX936.977.54
+0.81%
Vanguard Russell 1000 Growth Index I
GIDWX20.040.13
+0.65%
Goldman Sachs US Eq Div and Premium R6
CAVAX18.710.04
+0.21%
SEI Catholic Values Equity F (SCVT)
RYOIX86.56-2.00
-2.26%
Rydex Biotechnology Inv